125 Medical And Healthcare companies

We create and invest in healthcare and technology companies that impact lives all over the world.

Forging the future of health & security.

We are an early-stage growth equity firm funding big ideas in healthcare and enterprise technology.

We grow high value, sustainable companies that benefit healthcare providers.

We make investments in healthcare innovation and technology endeavors, targeting Healthcare Artificial Intelligence (AI) growth startup companies.

Our mission is to provide better medical products and services to improve the quality of public healthcare while reducing cost.

This company hasn't shared a description yet.

A leading global VC firm with $9.5 billion in capital raised. We invest in the Technology & Consumer and Healthcare sectors.

We unite research, venture building, programs, and investments to make healthcare more affordable, accessible, and impactful.

Epidarex is a transatlantic venture capital firm led by a diverse team of early-stage investors building breakthrough life science companies in emerging hubs.

CVS Health Ventures is a dedicated corporate venture capital fund that works with high-potential, early-stage and growth-stage companies focused on making healt…

BioSTL drives collaborative efforts to advance innovation & entrepreneurship that build on St. Louis’ world-class medical & plant biosciences.

A science-driven venture capital fund.

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

Unlocking value together.

Early-stage funding for European life sciences companies.

Investing in innovation for impact. Reduce cancer mortality and advance health equity.

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.

Define Ventures is one of the largest early-stage venture firms focused on investing in digital-health companies.

Adjuvant is a new type of investment firm. We finance the most promising life science technologies for high-burden public health challenges.